Plenary Session

Un podcast de Vinay Prasad, MD MPH

Catégories:

387 Épisodes

  1. QuANTUM - Quizartinib Front Line - Ethics of Global Trials

    Publié: 15/06/2022
  2. 4.67 Teclistimab for R/R Multiple Myeloma

    Publié: 09/06/2022
  3. 4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??

    Publié: 08/06/2022
  4. 4.65 DESTINY BREAST 04 - A complex trial to deconstruct

    Publié: 07/06/2022
  5. 4.64 - DETERMINATION - Should we still use transplant Myeloma?

    Publié: 06/06/2022
  6. 4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer

    Publié: 05/06/2022
  7. 4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial

    Publié: 04/06/2022
  8. 4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis

    Publié: 27/05/2022
  9. 4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods

    Publié: 21/05/2022
  10. 4.59 - How to be a better reader of case control studies

    Publié: 17/05/2022
  11. 4.58 - Myeloma is a broken field - New BLOOD Paper!

    Publié: 14/05/2022
  12. 4.57 - COVID19 and the Failures of Public Health w/ Leslie Bienen

    Publié: 06/05/2022
  13. 4.56 - Fifth Installment of the brilliant Zeb Jamrozik

    Publié: 04/05/2022
  14. 4.55 - Compilation Of Recent Covid Monologues

    Publié: 01/05/2022
  15. 4.54 - Eric Collisson Professor, GI Oncologist, Physician Scientist

    Publié: 30/04/2022
  16. 4.53 John Ioannidis lectures the VKPrasad Lab about COVID19

    Publié: 27/04/2022
  17. 4.52 Vinay Prasad Gives a Lecture on COVID19 to a General Audience

    Publié: 24/04/2022
  18. 4.51 - Vinay Prasad is Interviewed by Kristina Jenei About Academic Medicine

    Publié: 22/04/2022
  19. 4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

    Publié: 21/04/2022
  20. 4.49 - Malignant Book Club Part 3 Audio

    Publié: 15/04/2022

6 / 20

A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California, San Francisco. Tweet your feedback to @Plenary_Session or e-mail [email protected].

Visit the podcast's native language site